25,650.87
+437.56
(+1.74%)
8,555.03
+169.79
(+2.02%)
4,569.80
+101.32
(+2.27%)
3,930.12
-11.97
(-0.304%)
13,516.97
-108.15
(-0.794%)
79,784.6100
-1,485.7600
(-1.828%)
26/02/2026 13:03
大行報告 | 滙控績後最新評級/目標價,生物股邊隻好?一表盡掌握
.三間大行績後看好滙控(00005),其中華泰看好166.07元
.瑞銀上調生物股,其中藥明康德(02359)目標價由138.4元上調至153.1元
.瑞銀下調科濟藥業(02171)及諾誠健華(09969)目標,分別看27元及21.1元
1069,,新聞,專題透視,reports